Palleos, a European provider of clinical research services, and Starodub, a renowned Dutch consulting company, specializing in regulatory, quality, operations and improvements, announced a strategic partnership to offer comprehensive support for pharmaceutical companies navigating the complex regulatory landscape of clinical trials in Europe and beyond.
This collaboration combines Palleos’ expertise in clinical trial execution with Starodub’s deep knowledge of regulatory strategies, allowing sponsors to benefit from a seamless and efficient pathway from preclinical development to market approval. The partnership is particularly well-suited to assist sponsors outside of Europe in successfully entering the European market.
Under the terms of the agreement, Starodub will provide regulatory guidance and support to Palleos’ sponsors, including the development of robust regulatory strategies, assistance with interactions with the European Medicines Agency (EMA), such as Scientific Advice Meetings, and assistance with regulatory support programs, both before and after the initiation of clinical trials. Palleos will be responsible for the successful execution of the clinical studies, leveraging its deep expertise across 29 therapeutic areas and its proven ability to craft tailored solutions for clinical studies in Central and Eastern Europe.
“This partnership is a natural fit, combining our strengths to provide sponsors with a truly end-to-end solution,” said Philip Raeth, Managing Director at Palleos. “Starodub’s regulatory expertise is unparalleled, and their understanding of the EMA’s requirements will be invaluable to our clients, particularly those navigating the European regulatory environment for the first time. Together, we will help sponsors bring innovative therapies to patients faster and more efficiently.”
Valentyna Starodub, Founder and CEO at Starodub, added, “We are delighted to partner with Palleos, a company renowned for its commitment to quality and innovation in clinical research. Our complementary expertise will empower sponsors to proactively address regulatory challenges and optimize their clinical development programs, ultimately accelerating the availability of new medicines to patients in need. We are dedicated to ensuring our clients’ applications conform to all requirements, both scientific and regulatory.”
About Palleos:
Founded in 2005, Palleos is a full-service CRO dedicated to providing solutions for clinical studies in Europe. With expertise spanning 29 therapeutic areas, Palleos has successfully completed over 420 projects and enrolled over 74,580 patients, helping small to midsize biotech and medtech companies conduct efficient and successful clinical trials to achieve marketing authorization and expansion. Palleos: A CRO That Cares.
Website: https://www.palleos.com/
About Starodub
Founded in 2014, Starodub began as a regulatory consulting company and expanded in 2025 to include expertise in quality, operations, and process improvements. Based in the Netherlands, the home country for the EMA, Starodub supports pharmaceutical and medical device companies in the registration of small molecules, biologics, biotechnology-derived products, vaccines, and medical devices, while also addressing quality and manufacturing challenges. Starodub has completed over 400 projects and supported more than 300 clients. Every client application is guided to meet both scientific and regulatory requirements, ensuring a smooth and efficient path to market approval. At Starodub, quality and regulatory success go hand in hand.
Website: www.starodub.nl
Contact:
